| 摘要 |
<p>The invention relates to the treatment of impotence or erectile dysfunction by using prostaglandins that are selective EP2 or EP4 prostanoid receptor agonists. The prostaglandin medicaments can be formulated for intracavernous injection, or for transurethral or transdermal application.</p> |
